HB 2684 Summary

• Amends Oklahoma law (63 O.S. 2011, Section 1-729a) regarding the sale and distribution of abortion-inducing drugs, with an effective date of November 1, 2014.

• Prohibits any person except a licensed physician from providing abortion-inducing drugs, including mifepristone (RU-486) and misoprostol, with specific requirements for physician qualifications and patient safety protocols.

• Requires physicians to follow FDA-approved protocols (specifically the Mifeprex regimen) for administering abortion-inducing drugs, including providing patient education materials, obtaining signed patient agreements, and documenting the patient's gestational age and intrauterine pregnancy location.

• Mandates that physicians administer the drugs in their physical presence, schedule follow-up visits 12-18 days after administration, and report any incomplete abortions, severe bleeding, adverse reactions, or hospitalizations to the drug manufacturer and relevant state medical board within 60 days.

• Establishes civil liability allowing pregnant women, the biological father (if married), or maternal grandparents to sue for damages against physicians who knowingly or recklessly violate these provisions; exempts the pregnant woman herself from liability.